library.onepin.app/hcg Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Hormonal Glycoprotein hormone (37 kDa)FDA-approved medicineControlled substancePrescription drug

HCG

Human Chorionic Gonadotropin · Pregnyl

250-500 IU per injection – 1000-1500 IU SubQ 2-3 times per week
LH receptor agonistFDA-approved medicationGonadotropin

Human Chorionic Gonadotropin (HCG) is a naturally occurring glycoprotein hormone (~37 kDa) composed of two subunits (alpha and beta). The alpha subunit is shared with LH, FSH, and TSH; the beta subunit confers biological specificity. HCG mimics luteinizing hormone (LH) by binding to LH/CG receptors on Leydig cells in the testes, stimulating intratesticular testosterone production and preventing testicular atrophy during exogenous testosterone replacement therapy (TRT). It is FDA-approved for hypogonadism and certain fertility indications. HCG is essential in TRT protocols to maintain testicular function, fertility potential, and intratesticular hormonal milieu.

Quick Start
Route
SubQ or IM injection
Start low
250-500 IU SubQ
Frequency
2-3 times per week
Timing
No fasting requirement

SubQ or IM. Consistent timing. Often every other day or 2-3x per week. Pin alone.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
250-500 IU per injection · SubQ or IM injection · 2-3 times per week
conservative starter
250-500 IU per injection
2-3 times per week
Standard
TRT Testicular Preservation
250-500 IU · SubQ · 2x Weekly
human clinical trial · Coviello et al. 2005 (J Clin Endocrinol Metab)
Inject alongside TRT to prevent testicular atrophy and preserve upstream hormone synthesis (pregnenolone/DHEA).
250-500 IU
2x Weekly
Intermediate
PCT / Fertility Monotherapy
1000-1500 IU · SubQ · 3x Weekly
human clinical trial · FDA Pregnyl label
High doses will heavily spike intratesticular aromatization, often requiring an AI like Arimidex.
1000-1500 IU
3x Weekly
01

How it works

HCG binds to LH/CG receptors on Leydig cells, activating cAMP/PKA signaling to stimulate steroidogenesis (testosterone, estradiol, progesterone, DHEA synthesis within the testes). This maintains intratesticular testosterone (ITT) concentrations, which are 50-100x higher than serum levels and essential for spermatogenesis. During TRT, exogenous testosterone suppresses pituitary LH secretion via negative feedback, causing Leydig cell inactivity and testicular atrophy. HCG replaces the missing LH signal, keeping Leydig cells active and testes at normal volume. HCG also stimulates aromatase activity in Leydig cells, which means estradiol production increases alongside testosterone.

02

What to expect

Early
Days 1–7

Days 1-14: Testicular response begins. ITT levels start to recover if previously suppressed.

Mid
Weeks 2–4

Weeks 2-8: Testicular volume stabilizes or recovers. Estradiol levels may rise (monitor).

Later
Weeks 4–12

Ongoing: Continuous use alongside TRT. Monitor via labs (total T, free T, estradiol, LH, FSH, semen analysis if fertility relevant).

03

Evidence

HumanStrong
AnimalPresent
In-vitroPresent

Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.

Evidence boundary from the checked abstract: No patient became azoospermic during concomitant testosterone replacement and human chorionic gonadotropin therapy.

No patient became azoospermic during concomitant testosterone replacement and human chorionic gonadotropin therapy.

Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. The Journal of urology · 2013 · PMID 23260550

Evidence scope. This entry supports only the exact statement quoted from the live abstract; it does not independently verify OnePin's displayed dose, route, frequency, formulation, population, or broader mechanism.

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Dose/route: 250-500 IU per injection; SubQ or IM injection; 2-3 times per week. No checked live PubMed abstract verified this exact displayed dose, route, and frequency for the same molecule/formulation and relevant population.

Primary safety claim: No primary safety text present in source JSON. No checked live PubMed abstract directly verified this source-JSON safety claim at the displayed formulation, route, and regimen.

04

The honest take

Testicular preservation during TRT

Well-established medical indication. Standard of care recommendation in TRT protocols.

Fertility preservation

FDA-approved for this purpose. Maintains spermatogenesis during exogenous testosterone use.

Weight loss (HCG diet)
Not supported

The HCG diet is not supported by evidence. FDA has warned against OTC HCG weight loss products. Any weight loss is from the 500-calorie diet, not HCG.

05

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Pin alone. HCG must not share a syringe with anything else, whatever the pharmacology says. Large glycoprotein (37 kDa). Always pin alone in separate syringe. Different molecular class from peptides.

Documented together

AnastrozoleAI manages estrogen from HCG-stimulated testosterone production.
BPC-157No direct interaction. Separate injection sites and syringes.
Testosterone CypionateHCG maintains testicular function, size, and fertility during TRT. Most common TRT adjunct.
EnclomipheneBoth support HPG axis from different angles. HCG mimics LH, enclomiphene blocks estrogen feedback.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

06

Side effects & safety

Commonly reported

  • Estradiol elevation (aromatase stimulation)
  • Water retention
  • Injection site irritation
  • Mood changes related to E2 fluctuation

Less common & notes

  • Gynecomastia if E2 is uncontrolled.
  • Testicular discomfort at higher doses.
  • Very rare: OHSS (ovarian hyperstimulation, relevant only in female fertility use).
  • Anti-HCG antibodies possible with long-term use but clinically rare.
07

Pharmacokinetics

Illustrative plasma concentration · 6 d
Half-life
33h
Peak · Tmax
6h
Elimination
165h
Bioavailability
~100%

SubQ

Duration of action
48-72 hours
Clearance

Renal (intact and degraded fragments)

Storage. BAC water reconstitution: 30-60 days refrigerated at 2-8C. Sterile water reconstitution: 24-48 hours only. BAC water is essential for multi-dose vials. Unreconstituted vials stable at room temperature or refrigerated per manufacturer. Protect from light.

08

Regulatory status

FDA-approved for hypogonadism, cryptorchidism, and certain fertility indications. Prescription required. WADA prohibited under S2. Compounded versions available. Schedule III in some contexts.

Put it to work

Calculate, log & track

Open HCG straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open HCG in the app →

Go deeper

The guide & community

The complete HCG walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.